Intel Capital leads $15 million round for Chronocam to develop visual sensors for cars, drones, and robots
Tuesday, October 25 Kieren McCarthy / The Register : Intel throws the ball long with sports, VR and IoT cash injections Lucas Matney / TechCrunch : Chronocam secures $15M to power its ‘biological eye’ computer vision system
Context & Ripple Effects
This round lands mid-buildout of Intel's computer vision portfolio: within six months the company had bought Itseez, co-founded by two former Intel researchers, for its IoT and autonomous-car push, then acquired Movidius, whose vision chips power drones and VR. The Chronocam investment adds a sensor-layer bet — a 'biological eye' approach — on top of those software and chip purchases.
Intel Capital doubled down weeks later with a $250M two-year commitment to autonomous vehicle technology, and the sensor thesis proved durable: it led TriEye's $17M round in 2019 and returned for TriEye's $74M raise alongside Samsung in 2021.
First-order effects
- Chronocam gets $15M led by Intel Capital to develop its event-based visual sensors for cars, drones, and robots, with Intel gaining early equity in a sensor layer its recent acquisitions don't cover.
Second-order effects
- TriEye's later funding path — an Intel Capital-led round in 2019, then a larger round with Samsung aboard — shows automotive vision sensing becoming a category where rival chipmakers back competing Israeli startups rather than build in-house.
Third-order effects
- If the acquire-plus-invest pattern holds, Intel positions itself as a full-stack vision supplier to the autonomy market — sensors, chips, and software sold together — while corporate venture arms become the primary funding channel for perception startups.
The trend: Chipmakers are assembling autonomous-machine vision stacks through a mix of acquisitions and corporate venture rounds, with Intel Capital repeatedly seeding the same sensor category across successive funding cycles.